The Innovation Ecosystem creates and connects the talent, resources, partnerships, and opportunities to tackle bio- and cryo-preservation’s greatest challenges and address critical human and ecosystem health needs.

Regenerative medicine, aquaculture, and other industries related to ATP-Bio are worth over $300B globally and are predicted to grow substantially by 2027.

Solid Organs / Tissues and Aquaculture markets are larger, more mature, with less growth. They are ripe for disruption from new technologies such as ATP-Bio. Regenerative medicine and cell therapies and MPS are emerging markets, with huge growth potential, and where ATP-Bio technologies can have a dramatic impact on that growth. ATP-Bio technologies are poised to improve all four of these markets, and thereby save more lives and feed more people.

Dan Chen, Ph.D., EMBA
Interim ATP-Bio Director, Strategic Partners & Innovation

Carla Pavone (UMN) Innovation Ecosystem Co-Lead

Carla Pavone, Ph.D.
Innovation Ecosystems Co-Lead

follow us

 
 

* Password protected access only